Occlutech’s Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation for Heart Failure (HF)

Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) patients with preserved (HFpEF) or reduced (HFrEF) ejection fraction. Heart failure (HF) is a serious condition characterized by the heart’s inability […]

thaipr.net

20 ม.ค. 64

PureCircle and Almendra Resolve U.S. Patent Litigation

Amicable settlement reached PureCircle and Almendra reached an amicable settlement in a patent dispute in the United States relating to Almendra’s Steviarome® products and use thereof. As of December 31, 2020, PureCircle and Almendra voluntarily resolved the litigation with all claims and counterclaims subsequently being dismissed. As part of the settlement, Almendra signed a license agreement […]

thaipr.net

20 ม.ค. 64

Mainstream Renewable Power signs EUR1 billion equity investment deal with Aker Horizons to deliver 5.5 GW global build-out programme by 2023

– Aker Horizons of Norway to take a 75% equity stake in Mainstream Renewable Power (“Mainstream” or “The Company”) valuing Mainstream at EUR1 billion including earn-out and subject to customary adjustments – Agreement enables Mainstream to accelerate its global expansion plan to bring 5.5 Gigawatts (GW) of assets to financial close by 2023 ahead of […]

thaipr.net

20 ม.ค. 64
1 3,182 3,183 3,184 3,185 3,186 3,301